Hepatitis C epidemiology and prevention

Knowledge market 3 (K3)
In programme
Wednesday, 23 November, 2022 - 13:20 to 14:50
View presentations

About

This session brings together a variety of studies focused on the epidemiology of hepatitis C infection, including interventions to reduce risk of hepatitis C infection. 

Chair

Hoj
Stine
  • Research Associate,
  • Centre de recherche du CHUM,
  • Canada

Type

Tracks

Keywords

Presentations

Wednesday, 23 November

13:20
Oral presentation

Assessing the impact of COVID-19 and associated control measures on interventions to prevent drug-related harm among people who inject drugs in Scotland

13:20 to 14:50
Knowledge market 3 (K3)
Kirsten Trayner
Oral presentation

Global incidence of hepatitis C virus (HCV) and HIV infection among people who inject drugs: A systematic review and meta-analysis

13:20 to 14:50
Knowledge market 3 (K3)
Adelina Artenie
Oral presentation

The Contribution of Unstable Housing to HIV and Hepatitis C Virus Transmission Among People Who Inject Drugs Globally, Regionally, and at Country Level: A Modelling Study

13:20 to 14:50
Knowledge market 3 (K3)
Jack Stone
Oral presentation

The effectiveness of low dead space syringes for reducing the risk of hepatitis C virus acquisition among people who inject drugs - findings from a national survey in UK

13:20 to 14:50
Knowledge market 3 (K3)
Peter Vickerman
View the programme